Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Buy
64
BBIO
BridgeBio Pharma
Last Price:
$35.60
Seasonality Move:
4.17%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.14 | Buy |
20-day SMA: | 28.13 | Buy |
50-day SMA: | 26.68 | Buy |
200-day SMA: | 26.64 | Buy |
8-day EMA: | 29.71 | Buy |
20-day EMA: | 28.51 | Buy |
50-day EMA: | 27.3 | Buy |
200-day EMA: | 26.9 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1 | Buy |
Relative Strength Index (14 RSI): | 75.89 | Buy |
Chaikin Money Flow: | 8388809 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.75 - 29.69) | Buy |
Bollinger Bands (100): | (24.29 - 28.39) | Buy |
BridgeBio Pharma Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.73 while BBIO 8-day simple moving average is 29.14, which is a Buy signal.
-
The stock price of BBIO is 33.73 while BridgeBio Pharma 20-day SMA is 28.13, which makes it a Buy.
-
BridgeBio Pharma 50-day simple moving average is 26.68 while BBIO share price is 33.73, making it a Buy technically.
-
BBIO stock price is 33.73 and BridgeBio Pharma 200-day simple moving average is 26.64, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Buy
64
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a BuyThe current BridgeBio Pharma [BBIO] share price is $33.73. The Score for BBIO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
6.4B
Price in USD:
33.73
Share Volume:
10.1M
BridgeBio Pharma 52-Week Range
52-Week High:
41.04
52-Week Low:
21.62
Buy
64
BridgeBio Pharma (BBIO)
is a Buy
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 33.73 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is not overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.73 while BBIO 8-day exponential moving average is 29.71, which is a Buy signal.
-
The stock price of BBIO is 33.73 while BridgeBio Pharma 20-day EMA is 28.51, which makes it a Buy.
-
BridgeBio Pharma 50-day exponential moving average is 27.30 while BBIO share price is 33.73, making it a Buy technically.
-
BBIO stock price is 33.73 and BridgeBio Pharma 200-day simple moving average is 26.90, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.19 per share, and an increase next year of $0.73 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 1, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 75.89, which suggest BridgeBio Pharma is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma is (26.75 - 29.69), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (24.29 - 28.39), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.